Liquid suppository composition of diclofenac sodium
US6488954B1 · kind B1 · utility
6Cited by
2References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 2001 |
| Grant date | Dec 3, 2002 |
| Priority date | — |
| Expiry date | Aug 24, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/15
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a liquid suppository composition comprising diclofenac sodium, poloxamer and at least one polymer select from the group consisting of polyethylene oxide and polyvinylpyrrolidone. The composition provides the advantages of. (1) a feel of foreign matter or discomfort does not occur when the composition is rectally administered; and (2) administration is easy and after rectal administration, the composition is neither leaked out from the anus nor shifted into the end of large intestine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.